233 related articles for article (PubMed ID: 36267655)
21. Structure-based pharmacophore modeling, virtual screening, and molecular dynamics simulation studies for identification of
Oduselu GO; Afolabi R; Ademuwagun I; Vaughan A; Adebiyi E
Front Med (Lausanne); 2022; 9():1022429. PubMed ID: 36714108
[No Abstract] [Full Text] [Related]
22. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
Jana S; Singh SK
J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
[TBL] [Abstract][Full Text] [Related]
23. New lead compounds identification against KRas mediated cancers through pharmacophore-based virtual screening and in vitro assays.
Ghufran M; Rehman AU; Ayaz M; Ul-Haq Z; Uddin R; Azam SS; Wadood A
J Biomol Struct Dyn; 2023; 41(16):8053-8067. PubMed ID: 36184737
[TBL] [Abstract][Full Text] [Related]
24. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1.
Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS
Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564
[TBL] [Abstract][Full Text] [Related]
25. Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling.
Albayati S; Uba AI; Yelekçi K
Mol Divers; 2022 Apr; 26(2):1005-1016. PubMed ID: 33846894
[TBL] [Abstract][Full Text] [Related]
26. Pharmacoinformatics and molecular dynamics simulation-based phytochemical screening of neem plant (Azadiractha indica) against human cancer by targeting MCM7 protein.
Ahammad F; Alam R; Mahmud R; Akhter S; Talukder EK; Tonmoy AM; Fahim S; Al-Ghamdi K; Samad A; Qadri I
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33834183
[TBL] [Abstract][Full Text] [Related]
27. Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modelling.
Berinyuy E; Soliman MES
Interdiscip Sci; 2017 Sep; 9(3):406-418. PubMed ID: 27165479
[TBL] [Abstract][Full Text] [Related]
28. Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and
Opo FADM; Moulay M; Zari A; Alqaderi A; Alkarim S; Zari T; Bhuiyan MA; Mahmoud MM; Aljoud F; Suhail M; Edris S; Ramadan WS; Kamal MA; Nemmiche S; Ahammad F
Front Pharmacol; 2022; 13():1027890. PubMed ID: 36457709
[TBL] [Abstract][Full Text] [Related]
29. Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations.
Halder D; Das S; Jeyaprakash RS
Mol Divers; 2023 Sep; ():. PubMed ID: 37715109
[TBL] [Abstract][Full Text] [Related]
30. Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics.
Jade DD; Pandey R; Kumar R; Gupta D
J Biomol Struct Dyn; 2022 Mar; 40(4):1702-1718. PubMed ID: 33034255
[TBL] [Abstract][Full Text] [Related]
31. Identification of potential drug target in malarial disease using molecular docking analysis.
Joseph Sahayarayan J; Soundar Rajan K; Nachiappan M; Prabhu D; Guru Raj Rao R; Jeyakanthan J; Hossam Mahmoud A; Mohammed OB; Morgan AMA
Saudi J Biol Sci; 2020 Dec; 27(12):3327-3333. PubMed ID: 33304138
[TBL] [Abstract][Full Text] [Related]
32. Natural Phytocompounds from Common Indian Spices for Identification of Three Potential Inhibitors of Breast Cancer: A Molecular Modelling Approach.
Hazra S; Ray AS; Rahaman CH
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235128
[TBL] [Abstract][Full Text] [Related]
33. Halting aberrant DNA methylation via in silico Identification of potent inhibitors of DNMT3B enzyme: Atomistic insights.
Mtetwa LM; Salifu EY; Omolo CA; Soliman ME; Faya M
Comput Biol Chem; 2023 Aug; 105():107909. PubMed ID: 37418952
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel scaffolds targeting SIRT3 through molecular modeling techniques for the treatment of Hepatocellular carcinoma.
Maya Ramírez CE; Shokat Z; Sufyan M; Rehman MT; AlAjmi MF; Rather GM
J Biomol Struct Dyn; 2023 Sep; ():1-10. PubMed ID: 37705289
[TBL] [Abstract][Full Text] [Related]
35. In silico identification of potential inhibitors against shikimate dehydrogenase through virtual screening and toxicity studies for the treatment of tuberculosis.
Isa MA; Majumdar RS; Haider S
Int Microbiol; 2019 Mar; 22(1):7-17. PubMed ID: 30810932
[TBL] [Abstract][Full Text] [Related]
36. Identification of Inhibitors against Metastasis Protein "
Mishra S; Singh S
Pharmacogn Mag; 2018 Jan; 13(Suppl 4):S742-S748. PubMed ID: 29491627
[TBL] [Abstract][Full Text] [Related]
37. Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation.
Raafat A; Mowafy S; Abouseri SM; Fouad MA; Farag NA
Comput Biol Med; 2022 Jul; 146():105526. PubMed ID: 35487125
[TBL] [Abstract][Full Text] [Related]
38. Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated
Sharma S; Srivastava S; Shrivastava A; Malik R; Almalki F; Saifullah K; Alam MM; Shaqiquzzaman M; Ali S; Akhter M
J Biomol Struct Dyn; 2020 Nov; 38(18):5349-5361. PubMed ID: 31813365
[TBL] [Abstract][Full Text] [Related]
39. Pharmacophore- based virtual screening, 3D- QSAR, molecular docking approach for identification of potential dipeptidyl peptidase IV inhibitors.
Shah BM; Modi P; Trivedi P
J Biomol Struct Dyn; 2021 Apr; 39(6):2021-2043. PubMed ID: 32242496
[TBL] [Abstract][Full Text] [Related]
40. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.
Chaudhari P; Bari S
Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
